Clinical Trials on Malignancies, Hematologic in Australia
Total 985 results
-
Bayside HealthThe Alfred; The Leukaemia Foundation of VictoriaUnknownRCT to Investigate Whether an Exercise Programme Improves the Physical Performance and QOL After BMTHematological MalignanciesAustralia
-
Antengene Therapeutics LimitedBristol-Myers SquibbRecruitingSolid Tumor | Hematological MalignancyAustralia
-
Senti BiosciencesRecruitingAML/MDS | CD33 Expressing Hematological Malignancies | FLT3 Expressing Hematological MalignanciesUnited States, Australia
-
Hutchison Medipharma LimitedIqvia Pty LtdUnknownHematologic MalignanciesAustralia
-
Antengene Discovery LimitedRecruitingAdvanced Solid Tumors | Hematological MalignanciesAustralia
-
Kite, A Gilead CompanyEnrolling by invitationSolid and Hematological MalignanciesUnited States, Netherlands, Japan, Australia, France, Israel, Germany, Canada, United Kingdom
-
AstraZenecaRecruitingHematological MalignanciesUnited States, Spain, Korea, Republic of, Italy, China, Japan, Taiwan, Australia, Germany
-
Melbourne HealthActive, not recruitingHaematological MalignancyAustralia
-
Atridia Pty Ltd.CompletedSolid Tumors and Hematologic MalignancyAustralia
-
Elisabethinen HospitalPfizerTerminated
-
Ascentage Pharma Group Inc.RecruitingHematologic MalignanciesUnited States, Australia
-
Medical University of ViennaCompleted
-
Robert Krause, MDCompletedInvasive Fungal Infection | Hematological Malignancy | Receipt of Solid Organ TransplantAustria
-
AstraZenecaParexelActive, not recruitingAdvanced Haematological MalignanciesSpain, United States, Canada, Korea, Republic of, Poland, Australia, France, United Kingdom, Ireland
-
AbbVieRecruitingHematologic MalignanciesUnited States, Australia
-
AbbVieGenentech, Inc.Active, not recruitingNon-Hodgkin's Lymphoma | Hematological Malignancies | Chronic Lymphoid Leukemia | CD20-Positive Lymphoid MalignanciesUnited States, Australia
-
Curon Biopharmaceutical (Australia) Co Pty LtdNovotech (Australia) Pty LimitedTerminatedRelapsed Lymphoid Malignancies | Refractory Lymphoid MalignanciesAustralia
-
CRISPR Therapeutics AGEnrolling by invitationHematologic Malignancy | Solid MalignancyUnited States, Australia
-
Monash UniversityRecruitingHypogammaglobulinemia | Haematological MalignancyAustralia
-
AstraZenecaTerminatedStudy of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological MalignanciesHaematological MalignanciesFrance, Italy, United States, Korea, Republic of, Germany, Australia
-
AccentureCompletedHematologic MalignanciesKorea, Republic of, Australia, Canada
-
Melbourne HealthPeter MacCallum Cancer Centre, Australia; Western Sydney Local Health District and other collaboratorsEnrolling by invitationCytomegalovirus Infections | Immune Suppression | Haematological Malignancy | Organ or Tissue Transplant; ComplicationsAustralia
-
BeiGeneCompletedB-cell MalignanciesAustralia
-
Clover Biopharmaceuticals AUS Pty LtdCompletedPeritoneal MalignanciesAustralia
-
Humanigen, Inc.SuspendedMyelodysplastic Syndrome (MDS) | Myelofibrosis (MF)United States, Australia
-
Novartis PharmaceuticalsCompletedLymphoma | Leukemia | Multiple MyelomaUnited States, Germany, Australia
-
Centre Hospitalier Universitaire VaudoisUnknownHematologic Diseases | Hematologic Malignancy | Invasive Mold Infections | Breakthrough Invasive Mold InfectionsSwitzerland, Austria, Germany
-
GlaxoSmithKlineCompletedNeoplasmsSpain, United States, Korea, Republic of, United Kingdom, Australia
-
Heidelberg UniversityCompleted
-
Merck Sharp & Dohme LLCRecruitingSolid Tumors | Hematologic MalignanciesUnited States, Poland, Brazil, Ukraine, Argentina, Australia, Austria, Belgium, Canada, Chile, China, Colombia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Israel, Italy, Japan, Korea, Republic... and more
-
Eucure (Beijing) Biopharma Co., LtdCompletedAdvanced Solid MalignanciesAustralia
-
Jiangsu HengRui Medicine Co., Ltd.CompletedAdvanced MalignanciesAustralia, China
-
Gilead SciencesCompletedMyeloid MalignanciesUnited States, Australia, United Kingdom
-
BeiGeneCompletedB-cell MalignanciesUnited States, Korea, Republic of, Australia, New Zealand, United Kingdom, Italy
-
Medical University of ViennaRoche Pharma AG; Allcyte GmbHRecruitingRefractory Acute Myeloid Leukemia | Advanced Lymphoma | Refractory Lymphoma | Refractory Leukemia | Refractory T-Cell LymphomaAustria
-
Haisco Pharmaceutical Group Co., Ltd.RecruitingRelapsed/Refractory B-Cell MalignanciesChina, Australia
-
BeiGeneRecruitingMature B-Cell MalignanciesUnited States, Italy, Australia, New Zealand, Spain, Germany, United Kingdom
-
BeiGeneCompletedB-cell Lymphoid MalignanciesAustralia, Korea, Republic of, United States
-
Regeneron PharmaceuticalsSanofiCompletedMalignanciesUnited States, Korea, Republic of, Australia, Ireland, United Kingdom
-
AbbVieGenentech, Inc.; AmgenTerminatedAcute Myeloid Leukemia | Non-Hodgkin's Lymphoma | Diffuse Large B-cell LymphomaUnited States, Australia, Germany
-
Innovent Biologics (Suzhou) Co. Ltd.RecruitingSolid Malignancies or LymphomasAustralia
-
Merck Sharp & Dohme LLCRecruitingLymphoma, B-Cell | Lymphoma, Non-Hodgkin | Hodgkin DiseaseUnited States, Australia, Canada, Germany, Israel, Italy
-
University of SydneyUniversity of Roma La Sapienza; Australasian Bone Marrow Transplant Recipient... and other collaboratorsRecruiting
-
PfizerHospira, now a wholly owned subsidiary of PfizerCompleted
-
CSL LimitedCompletedIdiopathic Thrombocytopenic Purpura (ITP)Australia
-
The Hospital for Sick ChildrenBristol-Myers SquibbTerminatedRefractory or Recurrent Hypermutated Malignancies | Biallelic Mismatch Repair Deficiency (bMMRD) Positive PatientsUnited States, France, Canada, Australia, Israel
-
Bayside HealthNational Health and Medical Research Council, Australia; Monash UniversityRecruiting
-
AmgenTerminatedAcute Myeloid Leukemia | Multiple Myeloma | AML | Myelodysplastic Syndrome | MDS | Non-Hodgkins Lymphoma | NHLUnited States, Australia, Italy, France, Greece, Japan
-
Eli Lilly and CompanyActive, not recruitingNeoplasms, HematologicUnited States, Germany, Australia, Sweden, France, Spain, Italy, Austria, Canada
-
Therapeutic Advances in Childhood Leukemia ConsortiumRecruitingLymphoma, B-Cell | Hodgkin Lymphoma | Lymphoblastic Lymphoma | Lymphoma, T-Cell | AML | Hematologic Malignancy | MDS | Acute Undifferentiated Leukemia | ALL | Mixed Phenotype Acute Leukemia | BPDCNUnited States, Australia